We are live on ! Find out more

3,264 hedge funds and large institutions have $185B invested in Amgen in 2026 Q3 according to their latest regulatory filings, with 270 funds opening new positions, 1,239 increasing their positions, 1,264 reducing their positions, and 106 closing their positions.

New
Increased
Maintained
Reduced
Closed

155% more first-time investments, than exits

New positions opened: 270 | Existing positions closed: 106

49% more funds holding in top 10

Funds holding in top 10: 55 → 82 (+27)

3% more funds holding

Funds holding: 3,179 → 3,264 (+85)

2% less repeat investments, than reductions

Existing positions increased: 1,239 | Existing positions reduced: 1,264

2.32% less ownership

Funds ownership: 83.64% → 81.32% (-2.3%)

20% less call options, than puts

Call options by funds: $2.42B | Put options by funds: $3.02B

29% less capital inflows, than outflows

Capital inflows: $8.27B | Capital outflows: $11.6B

Holders
3,264
Holders Change
+85
Holders Change %
+2.67%
% of All Funds
39.75%
Holding in Top 10
82
Holding in Top 10 Change
+27
Holding in Top 10 Change %
+49.09%
% of All Funds
1%
New
270
Increased
1,239
Reduced
1,264
Closed
106
Calls
$2.42​B
Puts
$3.02​B
Net Calls
-⁠$597​M
Net Calls Change
-⁠$329​M

AMGN Hedge Fund Activity: Q3 2026 in Review

3,264 of the 8,212 institutional investors tracked by Wall St. Rank reported a position in Amgen (AMGN) for Q3 2026, worth a combined $185B — up 13% from $163B a quarter earlier.

Buyers outnumbered sellers: 270 funds opened new AMGN positions and 106 closed out — a net gain of 164 holders — while 1,239 added to existing stakes and 1,264 trimmed.

The largest buyer was JP Morgan Chase, adding an estimated $1.28B. The largest seller was Royal Bank of Canada, cutting an estimated $1.92B.

  • 3,264 institutional investors held Amgen (AMGN) as of Q3 2026, up from 3,179 in Q2 2026.
  • Funds reported $185B of Amgen stock for Q3 2026, up 13% quarter-over-quarter.
  • 270 funds opened new Amgen positions in Q3 2026 and 106 closed out, a net change of +164 holders.
  • The largest Amgen buyer in Q3 2026 was JP Morgan Chase, an estimated $1.28B added.
  • The largest Amgen seller in Q3 2026 was Royal Bank of Canada, an estimated $1.92B sold.

Based on aggregated 13F filings for Q3 2026.